NEW YORK, March 12 - Bristol-Myers Squibb has promoted its director of genomics-based pharmaceutical research, Elliot Sigal, to senior vice president in charge of drug discovery and exploratory development, the company said Monday.

The advancement for Sigal represents a "real sign of Elliot's leadership," said BMS spokeswoman Tracy Furey. "He is so highly regarded that he's now leading the whole discovery organization" at BMS' Pharmaceutical Research Institute, she said. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.